PET/CT Scans to Evaluate Thyroid and Parathyroid Conditions
Studies whether PET/CT scan results help tell apart thyroid and parathyroid conditions in adults.
Plain-language title generated from the registry record
Registry title: PET-TC in Thyroid Evaluation
Key facts
- Where
- Bologna, ItalySee the site
Where in Italy
- Nuclear medicine, IRCCS, Azienda Ospedalierio-Universitaria di BolognaBologna, ItalyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Trial code
- NCT06852144
- Record updated
- 28 February 2025
- Original description
The thyroid gland may have a diffuse or focal uptake of numerous PET/CT radiopharmaceuticals and this may be correlated with underlying benign and malignant thyroid/parathyroid pathologies.Read full original descriptionShow less
Ruolo Della PET/TC Nella Valutazione di Patologia Tiroidea in un Centro di Medicina Nucleare ad Alto Volume Diagnostico
The thyroid gland may have a diffuse or focal uptake of numerous PET/CT radiopharmaceuticals and this may be correlated with underlying benign and malignant thyroid/parathyroid pathologies.
It is not clear at present if the uptake of the radiopharmaceutical alone is associated with a potential malignancy of the disease.
The aim of the study is to collect evidence and consolidate the diagnostic power of PET/CT, to identify any predictive parameters that can determine whether PET positivity/negativity can in the future avoid unnecessary tests such as needle aspiration.
Inclusion: For the retrospective part:; Patients aged >18 years,; Findings of hypercaptant of thyroid/parathyroid relevance to PET/CT or known thyroid or parathyroid pathology and subsequent execution of PET/CT according to normal clinical practice,; Patients with cytological examination derived from needle aspiration performed no more than 12 months time apart from PET/CT; Obtaining informed consent; For the prospective part:; Patients aged >18 years,; Finding hypercaptant findings of thyroid/parathyroid relevance to PET/CT or known thyroid or parathyroid pathology and subsequent execution of PET/CT according to normal clinical practice; Patients scheduled for agesult to be no more than 12 months; Obtaining informed consent.
Exclusion: Nothing.